European experts publish recommendations for treatment of acute lymphoblastic leukemia in adults

FHS
March 1, 2024
11:00 am

The treatment of acute lymphoblastic leukemia in adults is extremely complex, lengthy and very stressful for patients.

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce

January 15, 2024

2024 VC forecast: Clinical-stage CDMOs likely to have uptick in demand but specialization critical

Clinical-stage CDMOs should expect a rise in demand in 2024 as funding for early-stage biopharma stabilizes and biotechs may shed their in-house manufacturing to save

December 1, 2023

Opinion | Small Wins

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.